195 related articles for article (PubMed ID: 32292505)
1. The WW domains dictate isoform-specific regulation of YAP1 stability and pancreatic cancer cell malignancy.
Guo Q; Quan M; Dong J; Bai J; Wang J; Han R; Wang W; Cai Y; Lv YQ; Chen Q; Xu H; Lyu HD; Deng L; Zhou D; Xiao X; De Langhe S; Billadeau DD; Lou Z; Zhang JS
Theranostics; 2020; 10(10):4422-4436. PubMed ID: 32292505
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of Tyr188 in the WW domain of YAP1 plays an essential role in YAP1-induced cellular transformation.
Li YW; Guo J; Shen H; Li J; Yang N; Frangou C; Wilson KE; Zhang Y; Mussell AL; Sudol M; Farooq A; Qu J; Zhang J
Cell Cycle; 2016 Sep; 15(18):2497-505. PubMed ID: 27428284
[TBL] [Abstract][Full Text] [Related]
3. Structural features and ligand binding properties of tandem WW domains from YAP and TAZ, nuclear effectors of the Hippo pathway.
Webb C; Upadhyay A; Giuntini F; Eggleston I; Furutani-Seiki M; Ishima R; Bagby S
Biochemistry; 2011 Apr; 50(16):3300-9. PubMed ID: 21417403
[TBL] [Abstract][Full Text] [Related]
4. Yap1-2 Isoform Is the Primary Mediator in TGF-β1 Induced EMT in Pancreatic Cancer.
Gao C; Quan MY; Chen QJ; Yang R; Wu Y; Liu JY; Lin ZY; Li X; Cai JT; Jiang TF; Xu L; Mossahebi-Mohammadi M; Guo Q; Zhang JS
Front Oncol; 2021; 11():649290. PubMed ID: 34094936
[TBL] [Abstract][Full Text] [Related]
5. Enhanced nuclear localization of YAP1-2 contributes to EGF-induced EMT in NSCLC.
Guo Q; Quan MY; Xu L; Cai Y; Cai JT; Li X; Feng G; Chen A; Yang W; Dhlamini Q; Jiang TF; Shen C; Chen C; Zhang JS
J Cell Mol Med; 2022 Feb; 26(4):1013-1023. PubMed ID: 35014181
[TBL] [Abstract][Full Text] [Related]
6. The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis.
Yi C; Shen Z; Stemmer-Rachamimov A; Dawany N; Troutman S; Showe LC; Liu Q; Shimono A; Sudol M; Holmgren L; Stanger BZ; Kissil JL
Sci Signal; 2013 Sep; 6(291):ra77. PubMed ID: 24003254
[TBL] [Abstract][Full Text] [Related]
7. Gli1 interacts with YAP1 to promote tumorigenesis in esophageal squamous cell carcinoma.
Wang C; Cheng L; Song S; Wu S; Sun G
J Cell Physiol; 2020 Nov; 235(11):8224-8235. PubMed ID: 31957872
[TBL] [Abstract][Full Text] [Related]
8. COPB2 promotes cell proliferation and tumorigenesis through up-regulating YAP1 expression in lung adenocarcinoma cells.
Pu X; Wang J; Li W; Fan W; Wang L; Mao Y; Yang S; Liu S; Xu J; Lv Z; Xu L; Shu Y
Biomed Pharmacother; 2018 Jul; 103():373-380. PubMed ID: 29674272
[TBL] [Abstract][Full Text] [Related]
9. LncRNA HOTAIR promotes the migration and invasion of cervical cancer through DNMT3B/LATS1/ YAP1 pS127 axis.
Zhang Z; Zhou X; Li J; Meng Q; Zheng P
Reprod Biol; 2024 Jun; 24(2):100893. PubMed ID: 38754347
[TBL] [Abstract][Full Text] [Related]
10. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.
Kang W; Huang T; Zhou Y; Zhang J; Lung RWM; Tong JHM; Chan AWH; Zhang B; Wong CC; Wu F; Dong Y; Wang S; Yang W; Pan Y; Chak WP; Cheung AHK; Pang JCS; Yu J; Cheng ASL; To KF
Cell Death Dis; 2018 Jan; 9(2):92. PubMed ID: 29367737
[TBL] [Abstract][Full Text] [Related]
11. TEAD4 promotes colorectal tumorigenesis via transcriptionally targeting YAP1.
Tang JY; Yu CY; Bao YJ; Chen L; Chen J; Yang SL; Chen HY; Hong J; Fang JY
Cell Cycle; 2018; 17(1):102-109. PubMed ID: 29157094
[TBL] [Abstract][Full Text] [Related]
12. The transcription factor RUNX2 fuels YAP1 signaling and gastric cancer tumorigenesis.
Guo Z; Zhou K; Wang Q; Huang Y; Ji J; Peng Y; Zhang X; Zheng T; Zhang Z; Chong D; Yang Z
Cancer Sci; 2021 Sep; 112(9):3533-3544. PubMed ID: 34160112
[TBL] [Abstract][Full Text] [Related]
13. Mu-KRAS attenuates Hippo signaling pathway through PKCι to sustain the growth of pancreatic cancer.
Wang P; Zhang H; Yang J; Li Z; Wang Y; Leng X; Ganapathy S; Isakson P; Chen C; Zhu T
J Cell Physiol; 2020 Jan; 235(1):408-420. PubMed ID: 31230347
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the YAP1 oncogene in clear cell renal cell carcinoma is associated with poor outcome.
Rybarczyk A; Klacz J; Wronska A; Matuszewski M; Kmiec Z; Wierzbicki PM
Oncol Rep; 2017 Jul; 38(1):427-439. PubMed ID: 28504812
[TBL] [Abstract][Full Text] [Related]
15. STUB1 suppresseses tumorigenesis and chemoresistance through antagonizing YAP1 signaling.
Tang DE; Dai Y; Lin LW; Xu Y; Liu DZ; Hong XP; Jiang HW; Xu SH
Cancer Sci; 2019 Oct; 110(10):3145-3156. PubMed ID: 31393050
[TBL] [Abstract][Full Text] [Related]
16. Evidence for discrete modes of YAP1 signaling via mRNA splice isoforms in development and diseases.
Vrbský J; Vinarský V; Perestrelo AR; De La Cruz JO; Martino F; Pompeiano A; Izzi V; Hlinomaz O; Rotrekl V; Sudol M; Pagliari S; Forte G
Genomics; 2021 May; 113(3):1349-1365. PubMed ID: 33713822
[TBL] [Abstract][Full Text] [Related]
17. Alternative splicing reverses the cell-intrinsic and cell-extrinsic pro-oncogenic potentials of YAP1.
Ben C; Wu X; Takahashi-Kanemitsu A; Knight CT; Hayashi T; Hatakeyama M
J Biol Chem; 2020 Oct; 295(41):13965-13980. PubMed ID: 32763976
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of Yes Associated Protein 1 expression reduces cell proliferation and clonogenicity of pancreatic cancer cells.
Diep CH; Zucker KM; Hostetter G; Watanabe A; Hu C; Munoz RM; Von Hoff DD; Han H
PLoS One; 2012; 7(3):e32783. PubMed ID: 22396793
[TBL] [Abstract][Full Text] [Related]
19. Up-regulated acylglycerol kinase (AGK) expression associates with gastric cancer progression through the formation of a novel YAP1-AGK-positive loop.
Huang S; Cao Y; Guo H; Yao Y; Li L; Chen J; Li J; Xiang X; Deng J; Xiong J
J Cell Mol Med; 2020 Oct; 24(19):11133-11145. PubMed ID: 32827244
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E
Kim HB; Kim M; Park YS; Park I; Kim T; Yang SY; Cho CJ; Hwang D; Jung JH; Markowitz SD; Hwang SW; Yang SK; Lim DS; Myung SJ
Gastroenterology; 2017 Feb; 152(3):616-630. PubMed ID: 27864128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
